Hood River Capital Management’s Transmedics TMDX Stock Holding History

Hood River Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.9M	Buy	751,133 +51,363	+7%	+$4.35M	0.36%	87
2026 Q1	$69.6M	Buy	699,770 +9,413	+1%	+$1.23M	0.7%	49
2025 Q4	$84M	Buy	690,357 +11,920	+2%	+$1.5M	0.92%	39
2025 Q3	$76.1M	Sell	678,437 -1,410	-0.2%	-$165K	0.9%	38
2025 Q2	$91.1M	Sell	679,847 -115,924	-15%	-$12.7M	1.27%	21
2025 Q1	$53.5M	Buy	+795,771	New	+$54.7M	0.91%	46
2024 Q4	–	Sell	-344,551	Closed	-$54.1M	–	178
2024 Q3	$54.1M	Buy	344,551 +219,377	+175%	+$33.8M	0.87%	44
2024 Q2	$18.9M	Buy	+125,174	New	+$15M	0.39%	84

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Hood River Capital Management's TMDX Position: Q2 2026 in Review

Hood River Capital Management increased its Transmedics (TMDX) stake by 7.3% in Q2 2026, buying an estimated $4.35M and bringing the position to 751,133 shares worth $49.9M. The position accounts for 0.36% of the portfolio, ranked #87.

Hood River Capital Management first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $91.1M in Q2 2025. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Hood River Capital Management held 751,133 shares of Transmedics worth $49.9M as of Q2 2026.
Hood River Capital Management bought 51,363 Transmedics shares in Q2 2026, an estimated $4.35M.
Transmedics made up 0.36% of Hood River Capital Management's portfolio in Q2 2026, its #87 holding.
Hood River Capital Management first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
Hood River Capital Management's Transmedics position peaked at $91.1M in Q2 2025.
374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Hood River Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.